Williams, R.T., et al
How soon will I see noticeable weight loss
FDA-approved GLP-1 receptor agonists include semaglutide (Ozempic, Wegovy, Rybelsus), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), lixisenatide (Adlyxin), exenatide (Bydureon BCise), and tirzepatide (Mounjaro, Zepbound)though tirzepatide is technically a dual GIP/GLP-1 receptor agonist
This would be even more pronounced in patients with subclinical gallbladder disease
In cases where L-carnitine supplementation proves ineffective or contraindicated, exploring alternative interventions such as dietary modifications, lifestyle changes, or pharmacological agents targeting related pathways may be necessary to address metabolic stress and improve oocyte quality